LEMBOREXANT

LEMBOREXANT was reported 2946 times

LEMBOREXANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYTOMEGALOVIRUS PANCREATITIS 2 0.2000
1 INFANTILE CORTICAL HYPEROSTOSIS 2 0.0909
2 OCULAR DYSMETRIA 3 0.0857
3 SLEEP PARALYSIS 88 0.0599
4 LUNG ADENOCARCINOMA STAGE II 2 0.0588
5 SUSPECTED DRUG-INDUCED LIVER INJURY 6 0.0300
6 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA 2 0.0282
7 ENCHONDROMATOSIS 2 0.0233
8 GLOSSOPTOSIS 5 0.0228
9 IMMOBILISATION SYNDROME 4 0.0188
10 LARYNGOPHARYNGITIS 2 0.0180
11 WITHDRAWAL CATATONIA 3 0.0130
12 LABELLED DRUG-FOOD INTERACTION ISSUE 2 0.0118
13 DEPENDENT PERSONALITY DISORDER 2 0.0110
14 PORIOMANIA 2 0.0105
15 HANGING 2 0.0101
16 ACIDOSIS HYPERCHLORAEMIC 6 0.0101
17 IRREGULAR SLEEP WAKE RHYTHM DISORDER 2 0.0099
18 CD4 LYMPHOCYTES ABNORMAL 2 0.0095
19 ASPERGILLOMA 3 0.0094
20 KLEBSIELLA TEST POSITIVE 6 0.0092
21 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0090
22 RADIAL NERVE PALSY 3 0.0085
23 PHYSICAL DECONDITIONING 21 0.0082
24 INFECTED NEOPLASM 2 0.0080
25 WATER INTOXICATION 4 0.0079
26 PUTAMEN HAEMORRHAGE 2 0.0070
27 AVERSION 2 0.0069
28 KLEBSIELLA BACTERAEMIA 6 0.0063
29 LIPOPROTEIN (A) INCREASED 2 0.0061
30 SPUTUM RETENTION 6 0.0061
31 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 4 0.0060
32 AORTITIS 4 0.0058
33 IMMUNE-MEDIATED CHOLANGITIS 2 0.0056
34 PARASOMNIA 4 0.0056
35 LIP EROSION 4 0.0055
36 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
37 PERIODIC LIMB MOVEMENT DISORDER 2 0.0054
38 CHOLANGITIS ACUTE 4 0.0053
39 ELECTROCARDIOGRAM PR PROLONGATION 4 0.0052
40 UPPER RESPIRATORY TRACT INFLAMMATION 6 0.0050
41 CATAPLEXY 7 0.0049
42 RAPID EYE MOVEMENTS SLEEP ABNORMAL 2 0.0047
43 CRANIOFACIAL FRACTURE 4 0.0047
44 IMMUNE-MEDIATED HEPATIC DISORDER 9 0.0046
45 CONGESTIVE HEPATOPATHY 2 0.0045
46 SEXUALLY INAPPROPRIATE BEHAVIOUR 2 0.0043
47 DYSLALIA 3 0.0041
48 SYPHILIS 3 0.0041
49 MARASMUS 6 0.0039
50 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
51 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 2 0.0038
52 CARPAL TUNNEL DECOMPRESSION 4 0.0038
53 INFUSION SITE CELLULITIS 2 0.0038
54 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
55 RECTAL PERFORATION 2 0.0037
56 INTERLEUKIN LEVEL INCREASED 2 0.0036
57 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
58 ENANTHEMA 2 0.0035
59 HYPERTENSIVE ENCEPHALOPATHY 2 0.0034
60 NEUROPSYCHOLOGICAL SYMPTOMS 2 0.0033
61 GASTROINTESTINAL POLYP HAEMORRHAGE 2 0.0033
62 IMMUNE-MEDIATED LUNG DISEASE 6 0.0033
63 INFECTIOUS PLEURAL EFFUSION 5 0.0033
64 ORAL MUCOSA EROSION 4 0.0033
65 PREMATURE MENOPAUSE 3 0.0032
66 ABULIA 3 0.0032
67 CORTISOL INCREASED 2 0.0032
68 HYPERAESTHESIA TEETH 4 0.0032
69 CHOLINERGIC SYNDROME 2 0.0031
70 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
71 IMMUNE-MEDIATED MYOCARDITIS 5 0.0031
72 NASAL CRUSTING 2 0.0031
73 HYPERMAGNESAEMIA 2 0.0031
74 HALLUCINATION, TACTILE 2 0.0030
75 ALTERED STATE OF CONSCIOUSNESS 65 0.0030
76 FEMORAL NECK FRACTURE 15 0.0029
77 SUICIDE ATTEMPT 175 0.0029
78 HAEMORRHAGIC CEREBRAL INFARCTION 2 0.0028
79 CERVICAL RADICULOPATHY 2 0.0028
80 AMNIOTIC CAVITY INFECTION 2 0.0028
81 KETOSIS 3 0.0028
82 SEDATION COMPLICATION 7 0.0027
83 VANISHING BILE DUCT SYNDROME 3 0.0027
84 HYPERURICAEMIA 11 0.0027
85 VITH NERVE PARALYSIS 3 0.0026
86 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
87 PULMONARY ARTERY THROMBOSIS 2 0.0026
88 CREATINE KINASE INCREASED 2 0.0026
89 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 2 0.0025
90 ABDOMINAL SYMPTOM 2 0.0025
91 KETONURIA 2 0.0025
92 ASPHYXIA 20 0.0024
93 AORTIC DISSECTION 10 0.0024
94 RENAL ATROPHY 3 0.0024
95 SLEEP TERROR 10 0.0024
96 SLEEP DEFICIT 5 0.0024
97 SELF-DESTRUCTIVE BEHAVIOUR 2 0.0023
98 NIGHTMARE 78 0.0023
99 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
100 NASAL CAVITY CANCER 2 0.0022
101 MUSCLE SWELLING 2 0.0022
102 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
103 CYTOKINE RELEASE SYNDROME 43 0.0021
104 ATYPICAL MYCOBACTERIAL INFECTION 3 0.0021
105 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 7 0.0021
106 CARDIAC FAILURE CHRONIC 9 0.0021
107 HYPOREFLEXIA 4 0.0021
108 PNEUMONIA ASPIRATION 52 0.0021
109 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
110 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
111 NORMOCYTIC ANAEMIA 3 0.0020
112 PYELONEPHRITIS ACUTE 4 0.0020
113 HEPATIC FUNCTION ABNORMAL 76 0.0020
114 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0020
115 STEROID DIABETES 3 0.0020
116 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
117 IMMUNE-MEDIATED HEPATITIS 4 0.0020
118 NEURITIS 3 0.0019
119 AKINESIA 4 0.0019
120 LYMPHANGIOSIS CARCINOMATOSA 2 0.0019
121 METASTASES TO PLEURA 2 0.0019
122 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2 0.0019
123 PNEUMONIA BACTERIAL 17 0.0019
124 HYPERNATRAEMIA 9 0.0018
125 DEMENTIA WITH LEWY BODIES 2 0.0018
126 FAECES PALE 4 0.0018
127 MALIGNANT PLEURAL EFFUSION 3 0.0018
128 IMMUNE-MEDIATED HYPOTHYROIDISM 2 0.0018
129 SUICIDAL IDEATION 156 0.0017
130 HYPORESPONSIVE TO STIMULI 2 0.0017
131 POLYMYOSITIS 3 0.0017
132 NEUROLEPTIC MALIGNANT SYNDROME 20 0.0017
133 AORTIC VALVE STENOSIS 3 0.0017
134 HAEMATOMA MUSCLE 2 0.0017
135 SINUS NODE DYSFUNCTION 3 0.0016
136 AMPUTATION 2 0.0016
137 GLUCOSE URINE PRESENT 2 0.0016
138 PNEUMONIA VIRAL 5 0.0016
139 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
140 MIDDLE INSOMNIA 29 0.0016
141 DRUG TITRATION ERROR 4 0.0015
142 BILIARY OBSTRUCTION 2 0.0015
143 RESPIRATORY ACIDOSIS 6 0.0015
144 SOMNAMBULISM 10 0.0015
145 LUNG OPACITY 4 0.0015
146 EXTRADURAL HAEMATOMA 2 0.0015
147 CARDIAC FAILURE ACUTE 10 0.0015
148 COMPRESSION FRACTURE 8 0.0015
149 PSYCHIATRIC SYMPTOM 11 0.0015
150 MYASTHENIA GRAVIS 12 0.0015
151 CHOLANGITIS SCLEROSING 3 0.0015
152 INFUSION SITE RASH 2 0.0015
153 HEAD TITUBATION 2 0.0015
154 PSYCHOTIC SYMPTOM 3 0.0015
155 BRASH SYNDROME 2 0.0014
156 PRERENAL FAILURE 2 0.0014
157 HYPERKINESIA 3 0.0014
158 HYPOALBUMINAEMIA 11 0.0014
159 CONJUNCTIVAL HYPERAEMIA 5 0.0014
160 CEREBELLAR HAEMORRHAGE 2 0.0014
161 OCCUPATIONAL EXPOSURE TO PRODUCT 9 0.0014
162 JAW FRACTURE 3 0.0014
163 THERAPY NON-RESPONDER 62 0.0014
164 ABNORMAL DREAMS 38 0.0014
165 NODAL RHYTHM 2 0.0014
166 DRUG ERUPTION 24 0.0014
167 MYASTHENIA GRAVIS CRISIS 2 0.0013
168 HEPATITIS FULMINANT 4 0.0013
169 HYPERTHERMIA MALIGNANT 2 0.0013
170 INTERSTITIAL LUNG DISEASE 65 0.0013
171 SYMPTOM RECURRENCE 8 0.0013
172 MENTAL FATIGUE 2 0.0013
173 PARKINSONISM 13 0.0013
174 PNEUMONIA PSEUDOMONAL 2 0.0013
175 IMMUNE-MEDIATED ADVERSE REACTION 2 0.0013
176 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
177 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
178 PULMONARY TOXICITY 9 0.0013
179 DELIRIUM 44 0.0013
180 NASAL ULCER 2 0.0013
181 OESOPHAGEAL CANDIDIASIS 5 0.0013
182 NON-SMALL CELL LUNG CANCER 6 0.0013
183 ANTICONVULSANT DRUG LEVEL INCREASED 2 0.0012
184 SCHIZOPHRENIA 15 0.0012
185 SPRUE-LIKE ENTEROPATHY 6 0.0012
186 ENTEROCOLITIS 7 0.0012
187 HYPERAMMONAEMIA 6 0.0012
188 HALLUCINATION, AUDITORY 19 0.0012
189 HALLUCINATIONS, MIXED 5 0.0012
190 CEREBRAL INFARCTION 29 0.0012
191 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
192 CEREBELLAR INFARCTION 2 0.0012
193 DYSLIPIDAEMIA 6 0.0012
194 ERYTHEMA MULTIFORME 11 0.0012
195 EXPOSURE TO SARS-COV-2 2 0.0012
196 APLASIA PURE RED CELL 4 0.0012
197 CONCUSSION 9 0.0012
198 SERUM FERRITIN DECREASED 2 0.0012
199 HYPOPITUITARISM 2 0.0011
200 PSEUDOMONAL SEPSIS 2 0.0011
201 HANGOVER 4 0.0011
202 GASTROINTESTINAL OEDEMA 2 0.0011
203 LUNG TRANSPLANT 4 0.0011
204 ILEUS PARALYTIC 5 0.0011
205 ASPIRATION 12 0.0011
206 ESSENTIAL HYPERTENSION 2 0.0011
207 DISORGANISED SPEECH 2 0.0011
208 AMYLASE INCREASED 4 0.0011
209 SEDATION 28 0.0011
210 RENAL TUBULAR DISORDER 3 0.0011
211 HYPOGAMMAGLOBULINAEMIA 7 0.0011
212 CORONAVIRUS INFECTION 7 0.0011
213 HYPOPROTEINAEMIA 2 0.0011
214 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
215 HYPERTONIC BLADDER 3 0.0010
216 METABOLIC DISORDER 6 0.0010
217 PANIC DISORDER 4 0.0010
218 ALCOHOL INTERACTION 2 0.0010
219 ADVERSE DRUG REACTION 92 0.0010
220 CONCOMITANT DISEASE PROGRESSION 2 0.0010
221 NEPHROTIC SYNDROME 7 0.0010
222 JOINT NOISE 2 0.0010
223 INTENTIONAL OVERDOSE 65 0.0010
224 GENE MUTATION 2 0.0010
225 INFUSION SITE REACTION 3 0.0010
226 HYPERPHAGIA 4 0.0010
227 UNDERDOSE 73 0.0010
228 CORONARY ARTERY THROMBOSIS 2 0.0010
229 ENURESIS 4 0.0010
230 ADRENAL INSUFFICIENCY 12 0.0010
231 DYSCHEZIA 3 0.0010
232 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
233 POOR QUALITY SLEEP 21 0.0010
234 HYPERPARATHYROIDISM 2 0.0010
235 PANIC REACTION 7 0.0010
236 CAPILLARY LEAK SYNDROME 2 0.0010
237 LIVEDO RETICULARIS 2 0.0010
238 ABSCESS LIMB 4 0.0009
239 VENTRICULAR HYPOKINESIA 3 0.0009
240 STUPOR 3 0.0009
241 ANAL ABSCESS 5 0.0009
242 PEMPHIGOID 7 0.0009
243 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
244 BIPOLAR I DISORDER 2 0.0009
245 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
246 DELUSION 14 0.0009
247 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
248 PSEUDOMEMBRANOUS COLITIS 2 0.0009
249 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
250 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
251 HEPATIC CYST 3 0.0009
252 IMMUNE THROMBOCYTOPENIA 4 0.0009
253 CYTOMEGALOVIRUS COLITIS 2 0.0009
254 HYPOPHAGIA 22 0.0009
255 DISCOURAGEMENT 2 0.0009
256 DEPRESSIVE SYMPTOM 3 0.0009
257 COVID-19 PNEUMONIA 10 0.0008
258 SKIN ABRASION 4 0.0008
259 PLEURISY 5 0.0008
260 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
261 RASH VESICULAR 4 0.0008
262 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
263 CHOLANGITIS 5 0.0008
264 PERSECUTORY DELUSION 2 0.0008
265 PRESCRIBED UNDERDOSE 16 0.0008
266 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
267 CHRONIC SINUSITIS 3 0.0008
268 TUMOUR LYSIS SYNDROME 7 0.0008
269 MANIA 13 0.0008
270 FEEDING DISORDER 16 0.0008
271 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
272 INITIAL INSOMNIA 8 0.0008
273 PELVIC FRACTURE 6 0.0008
274 LIVER DISORDER 34 0.0008
275 HALLUCINATION, VISUAL 16 0.0008
276 SUDDEN DEATH 8 0.0008
277 CEREBRAL ATROPHY 3 0.0008
278 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
279 ANAESTHETIC COMPLICATION 2 0.0007
280 BLOOD SODIUM INCREASED 2 0.0007
281 NOCTURIA 9 0.0007
282 VITAMIN B12 DEFICIENCY 3 0.0007
283 SOMNOLENCE 149 0.0007
284 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
285 RED BLOOD CELL COUNT INCREASED 2 0.0007
286 DRUG LEVEL INCREASED 12 0.0007
287 DIZZINESS POSTURAL 7 0.0007
288 RESTLESSNESS 26 0.0007
289 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
290 CHOLECYSTITIS ACUTE 4 0.0007
291 OESOPHAGEAL STENOSIS 2 0.0007
292 INTERVERTEBRAL DISC DISORDER 3 0.0007
293 PURULENT DISCHARGE 3 0.0007
294 DRUG-INDUCED LIVER INJURY 22 0.0007
295 PARALYSIS 10 0.0007
296 SHOCK 16 0.0007
297 PYELONEPHRITIS 6 0.0007
298 STRESS CARDIOMYOPATHY 4 0.0007
299 URINE OUTPUT DECREASED 6 0.0007
300 DIVERTICULUM INTESTINAL 3 0.0007
301 DYSPHEMIA 3 0.0007
302 PARONYCHIA 3 0.0007
303 HYPOGLYCAEMIA 33 0.0007
304 MENINGITIS ASEPTIC 3 0.0007
305 HYPERCAPNIA 2 0.0007
306 HAEMOGLOBIN INCREASED 3 0.0007
307 EPILEPSY 20 0.0007
308 RECTAL CANCER 2 0.0007
309 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
310 PRODUCT DISTRIBUTION ISSUE 6 0.0006
311 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
312 NEUTROPHIL COUNT DECREASED 26 0.0006
313 INFUSION SITE PRURITUS 2 0.0006
314 COLITIS MICROSCOPIC 3 0.0006
315 HEPATITIS B REACTIVATION 2 0.0006
316 URINARY RETENTION 21 0.0006
317 SUBCUTANEOUS ABSCESS 3 0.0006
318 HUMERUS FRACTURE 3 0.0006
319 INFUSION SITE PAIN 8 0.0006
320 LIVER ABSCESS 2 0.0006
321 BACTERIAL SEPSIS 2 0.0006
322 INFUSION SITE HAEMORRHAGE 2 0.0006
323 NEAR DEATH EXPERIENCE 2 0.0006
324 ORGANISING PNEUMONIA 3 0.0006
325 RESTLESS LEGS SYNDROME 11 0.0006
326 PEPTIC ULCER 2 0.0006
327 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 3 0.0006
328 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
329 HALLUCINATION 45 0.0006
330 RENAL IMPAIRMENT 50 0.0006
331 AKATHISIA 8 0.0006
332 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
333 FOOT FRACTURE 11 0.0006
334 PRIAPISM 2 0.0006
335 DROOLING 4 0.0006
336 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
337 RIGHT VENTRICULAR FAILURE 4 0.0006
338 EAR PRURITUS 2 0.0006
339 CARDIOMEGALY 7 0.0006
340 SERUM FERRITIN INCREASED 3 0.0006
341 JAUNDICE CHOLESTATIC 2 0.0006
342 LYMPHOCYTE COUNT DECREASED 10 0.0006
343 GENERALISED OEDEMA 7 0.0006
344 ILEUS 7 0.0006
345 FOOD POISONING 3 0.0006
346 BRUXISM 3 0.0006
347 ANAL INCONTINENCE 5 0.0006
348 INTENTIONAL UNDERDOSE 4 0.0005
349 BLOOD PHOSPHORUS DECREASED 2 0.0005
350 HYPOMANIA 2 0.0005
351 PLEURAL EFFUSION 33 0.0005
352 TASTE DISORDER 11 0.0005
353 IRON DEFICIENCY ANAEMIA 5 0.0005
354 CYTOMEGALOVIRUS INFECTION 9 0.0005
355 FEELING DRUNK 4 0.0005
356 CARDIAC DYSFUNCTION 2 0.0005
357 COLON CANCER 8 0.0005
358 HYPOTHYROIDISM 17 0.0005
359 ARTERIOSCLEROSIS 5 0.0005
360 ABNORMAL BEHAVIOUR 21 0.0005
361 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
362 FRACTURE 10 0.0005
363 MYOCARDITIS 6 0.0005
364 COMMUNICATION DISORDER 2 0.0005
365 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
366 DEVICE RELATED INFECTION 8 0.0005
367 BLOOD URIC ACID INCREASED 3 0.0005
368 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
369 CONDITION AGGRAVATED 157 0.0005
370 POLYDIPSIA 2 0.0005
371 PNEUMOTHORAX 8 0.0005
372 MUSCLE RIGIDITY 6 0.0005
373 AZOTAEMIA 2 0.0005
374 SALIVARY HYPERSECRETION 5 0.0005
375 HEPATITIS CHOLESTATIC 3 0.0005
376 BLOOD PRESSURE DECREASED 33 0.0005
377 MENTAL IMPAIRMENT 12 0.0005
378 C-REACTIVE PROTEIN INCREASED 18 0.0005
379 DERMATITIS ACNEIFORM 3 0.0005
380 SHOCK HAEMORRHAGIC 4 0.0005
381 ARTHRITIS BACTERIAL 2 0.0005
382 EXTRAVASATION 2 0.0005
383 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
384 OLIGURIA 3 0.0005
385 TOOTH EXTRACTION 6 0.0005
386 GASTROINTESTINAL PERFORATION 2 0.0005
387 APATHY 7 0.0005
388 INFUSION SITE ERYTHEMA 4 0.0005
389 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
390 DYSKINESIA 19 0.0005
391 HYPERPROLACTINAEMIA 3 0.0005
392 HORDEOLUM 2 0.0005
393 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
394 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
395 IMMOBILE 2 0.0005
396 ORAL CANDIDIASIS 6 0.0005
397 PULMONARY CONGESTION 6 0.0005
398 HYPOKALAEMIA 21 0.0005
399 TOOTH FRACTURE 5 0.0005
400 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
401 THIRST 8 0.0004
402 POST-TRAUMATIC STRESS DISORDER 3 0.0004
403 JAUNDICE 12 0.0004
404 IMPAIRED GASTRIC EMPTYING 6 0.0004
405 DERMATITIS CONTACT 5 0.0004
406 DISEASE COMPLICATION 2 0.0004
407 DYSPAREUNIA 2 0.0004
408 PERFORMANCE STATUS DECREASED 2 0.0004
409 ATAXIA 5 0.0004
410 BACTERAEMIA 5 0.0004
411 CHOLECYSTITIS 5 0.0004
412 ENDOMETRIOSIS 2 0.0004
413 SLEEP APNOEA SYNDROME 8 0.0004
414 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
415 CYTOPENIA 5 0.0004
416 ASCITES 12 0.0004
417 RESPIRATORY DEPRESSION 5 0.0004
418 FEBRILE NEUTROPENIA 27 0.0004
419 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
420 THERAPY CHANGE 4 0.0004
421 INFLAMMATORY MARKER INCREASED 2 0.0004
422 HEPATIC ENZYME ABNORMAL 2 0.0004
423 FLUID INTAKE REDUCED 2 0.0004
424 INTESTINAL OBSTRUCTION 15 0.0004
425 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
426 HEAD DISCOMFORT 7 0.0004
427 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
428 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
429 HYPOTHERMIA 4 0.0004
430 PATHOLOGICAL FRACTURE 2 0.0004
431 DISSOCIATION 3 0.0004
432 HYPONATRAEMIA 22 0.0004
433 OSTEOMYELITIS 7 0.0004
434 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
435 FOETAL DEATH 2 0.0004
436 APNOEA 3 0.0004
437 TREATMENT NONCOMPLIANCE 21 0.0004
438 POLLAKIURIA 16 0.0004
439 BRAIN FOG 6 0.0004
440 TORSADE DE POINTES 3 0.0004
441 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
442 GASTRITIS 10 0.0004
443 HEPATIC STEATOSIS 7 0.0004
444 LIVER FUNCTION TEST INCREASED 8 0.0004
445 RHINITIS 3 0.0004
446 HYPOXIA 13 0.0004
447 PROTEINURIA 7 0.0004
448 BIPOLAR DISORDER 4 0.0004
449 FEELING JITTERY 7 0.0004
450 POLYURIA 3 0.0004
451 PLATELET COUNT DECREASED 39 0.0004
452 SPINAL COMPRESSION FRACTURE 3 0.0004
453 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
454 PRESCRIBED OVERDOSE 7 0.0004
455 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
456 HEMIPLEGIA 3 0.0004
457 HAEMORRHOIDS 7 0.0004
458 ORAL HERPES 7 0.0004
459 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
460 BRADYCARDIA 19 0.0004
461 MALNUTRITION 4 0.0004
462 MACULAR OEDEMA 2 0.0004
463 HYPERGLYCAEMIA 13 0.0004
464 FACE OEDEMA 6 0.0004
465 FEMUR FRACTURE 11 0.0004
466 MITRAL VALVE INCOMPETENCE 4 0.0004
467 INSOMNIA 94 0.0004
468 INTENTIONAL DOSE OMISSION 10 0.0004
469 SUBDURAL HAEMATOMA 5 0.0003
470 DRUG INTERACTION 55 0.0003
471 METASTASES TO LUNG 4 0.0003
472 SEPTIC SHOCK 15 0.0003
473 DECREASED APPETITE 80 0.0003
474 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
475 COVID-19 60 0.0003
476 HYPERTRIGLYCERIDAEMIA 2 0.0003
477 GRIP STRENGTH DECREASED 3 0.0003
478 IMMUNOSUPPRESSION 3 0.0003
479 PRODUCT COMMUNICATION ISSUE 3 0.0003
480 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
481 RHABDOMYOLYSIS 14 0.0003
482 PULMONARY MASS 5 0.0003
483 FALL 111 0.0003
484 STAPHYLOCOCCAL INFECTION 11 0.0003
485 INJECTION SITE VESICLES 2 0.0003
486 PANIC ATTACK 12 0.0003
487 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
488 INGUINAL HERNIA 2 0.0003
489 DYSPHAGIA 31 0.0003
490 SLEEP DISORDER 23 0.0003
491 ANGER 11 0.0003
492 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
493 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
494 FAECES DISCOLOURED 7 0.0003
495 PHARYNGITIS 4 0.0003
496 DEHYDRATION 43 0.0003
497 DEMENTIA 9 0.0003
498 THINKING ABNORMAL 6 0.0003
499 HEPATIC ENCEPHALOPATHY 3 0.0003
500 OXYGEN SATURATION DECREASED 18 0.0003
501 ACUTE KIDNEY INJURY 49 0.0003
502 FLANK PAIN 3 0.0003
503 PHOTOPSIA 2 0.0003
504 STEVENS-JOHNSON SYNDROME 7 0.0003
505 FOREIGN BODY SENSATION IN EYES 2 0.0003
506 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
507 AFFECT LABILITY 3 0.0003
508 DRUG RESISTANCE 8 0.0003
509 CARDIAC FAILURE 25 0.0003
510 PROCTALGIA 2 0.0003
511 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
512 ROAD TRAFFIC ACCIDENT 13 0.0003
513 ATELECTASIS 3 0.0003
514 DYSTONIA 6 0.0003
515 INCOHERENT 2 0.0003
516 HIATUS HERNIA 4 0.0003
517 HEPATITIS ACUTE 2 0.0003
518 PHARYNGEAL SWELLING 3 0.0003
519 MYELOSUPPRESSION 11 0.0003
520 CHOLELITHIASIS 10 0.0003
521 PRODUCT PREPARATION ISSUE 2 0.0003
522 BEDRIDDEN 4 0.0003
523 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 54 0.0003
524 MUSCULAR WEAKNESS 34 0.0003
525 FULL BLOOD COUNT DECREASED 6 0.0003
526 METASTASES TO LYMPH NODES 2 0.0003
527 DISCOMFORT 18 0.0003
528 SUBARACHNOID HAEMORRHAGE 3 0.0003
529 SEIZURE 34 0.0003
530 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
531 OSTEOPOROSIS 12 0.0003
532 DIABETIC KETOACIDOSIS 7 0.0003
533 PERIPHERAL COLDNESS 4 0.0003
534 TOXICITY TO VARIOUS AGENTS 49 0.0003
535 PARANOIA 5 0.0003
536 ENCEPHALITIS 2 0.0003
537 VENTRICULAR EXTRASYSTOLES 3 0.0003
538 LARGE INTESTINE POLYP 2 0.0003
539 COMPLETED SUICIDE 24 0.0003
540 ORAL DISCOMFORT 4 0.0003
541 AUTOIMMUNE HEPATITIS 2 0.0003
542 ORTHOSTATIC HYPOTENSION 5 0.0003
543 SCRATCH 3 0.0003
544 HEAD INJURY 9 0.0003
545 FEAR OF INJECTION 2 0.0003
546 BRONCHOSPASM 4 0.0003
547 RENAL DISORDER 13 0.0003
548 DECREASED ACTIVITY 3 0.0003
549 CELLULITIS 14 0.0003
550 OEDEMA 15 0.0003
551 FAECES SOFT 2 0.0003
552 MAJOR DEPRESSION 2 0.0003
553 LOSS OF CONSCIOUSNESS 35 0.0003
554 ERECTILE DYSFUNCTION 7 0.0003
555 HYPOPHOSPHATAEMIA 2 0.0003
556 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
557 CEREBRAL DISORDER 2 0.0003
558 BACTERIAL INFECTION 5 0.0003
559 NEPHROPATHY TOXIC 3 0.0003
560 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
561 FISTULA 3 0.0003
562 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
563 BLOOD POTASSIUM DECREASED 8 0.0003
564 DYSARTHRIA 10 0.0003
565 STATUS EPILEPTICUS 3 0.0003
566 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
567 MYOCARDIAL ISCHAEMIA 3 0.0003
568 GASTRIC ULCER 5 0.0003
569 HEPATOCELLULAR CARCINOMA 2 0.0003
570 PYREXIA 91 0.0003
571 HYPERTHERMIA 2 0.0003
572 BOWEL MOVEMENT IRREGULARITY 2 0.0003
573 HERPES ZOSTER 15 0.0003
574 LIPASE INCREASED 2 0.0003
575 RESPIRATORY FAILURE 19 0.0003
576 OVERDOSE 56 0.0003
577 PERICARDIAL EFFUSION 6 0.0003
578 MUSCULOSKELETAL CHEST PAIN 4 0.0003
579 COGNITIVE DISORDER 12 0.0003
580 HYPERKALAEMIA 9 0.0003
581 INFUSION RELATED REACTION 17 0.0003
582 NASAL CONGESTION 15 0.0003
583 MULTIPLE ALLERGIES 2 0.0003
584 AFFECTIVE DISORDER 2 0.0003
585 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
586 BLOOD ALBUMIN DECREASED 2 0.0003
587 DRUG INEFFECTIVE 332 0.0003
588 RENAL CYST 2 0.0003
589 GINGIVAL PAIN 2 0.0003
590 WRIST FRACTURE 3 0.0003
591 NEURALGIA 6 0.0002
592 OFF LABEL USE 215 0.0002
593 DYSURIA 9 0.0002
594 ABNORMAL FAECES 2 0.0002
595 SMALL INTESTINAL OBSTRUCTION 3 0.0002
596 HYPERCALCAEMIA 3 0.0002
597 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
598 ACUTE CORONARY SYNDROME 2 0.0002
599 EOSINOPHIL COUNT INCREASED 2 0.0002
600 DYSPNOEA EXERTIONAL 9 0.0002
601 PNEUMONIA 77 0.0002
602 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
603 BRAIN OEDEMA 3 0.0002
604 MOUTH ULCERATION 5 0.0002
605 ANAPHYLACTIC REACTION 13 0.0002
606 FACIAL PARALYSIS 2 0.0002
607 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
608 ANAPHYLACTIC SHOCK 6 0.0002
609 PANCYTOPENIA 13 0.0002
610 BLOOD MAGNESIUM DECREASED 2 0.0002
611 AGITATION 17 0.0002
612 HYSTERECTOMY 2 0.0002
613 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
614 AMENORRHOEA 4 0.0002
615 GROIN PAIN 2 0.0002
616 METASTASES TO LIVER 4 0.0002
617 SARS-COV-2 TEST POSITIVE 3 0.0002
618 PURPURA 2 0.0002
619 GASTROINTESTINAL INFECTION 2 0.0002
620 TREMOR 37 0.0002
621 PANCREATITIS ACUTE 5 0.0002
622 UVEITIS 3 0.0002
623 LIMB INJURY 6 0.0002
624 AGGRESSION 11 0.0002
625 PATHOGEN RESISTANCE 2 0.0002
626 MOVEMENT DISORDER 7 0.0002
627 RESPIRATORY ARREST 6 0.0002
628 RETINAL DETACHMENT 2 0.0002
629 INCREASED TENDENCY TO BRUISE 2 0.0002
630 MUSCLE TWITCHING 5 0.0002
631 CONSTIPATION 47 0.0002
632 HYPOMAGNESAEMIA 3 0.0002
633 HUNGER 3 0.0002
634 HEPATIC CIRRHOSIS 4 0.0002
635 TARDIVE DYSKINESIA 6 0.0002
636 PHOTOPHOBIA 4 0.0002
637 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
638 HAEMATOTOXICITY 2 0.0002
639 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
640 MYELODYSPLASTIC SYNDROME 3 0.0002
641 ERUCTATION 4 0.0002
642 GASTROENTERITIS 3 0.0002
643 MALIGNANT NEOPLASM PROGRESSION 21 0.0002
644 GAIT DISTURBANCE 39 0.0002
645 PSYCHOTIC DISORDER 6 0.0002
646 CARDIOMYOPATHY 3 0.0002
647 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
648 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
649 SINUS DISORDER 4 0.0002
650 EXTRAPYRAMIDAL DISORDER 5 0.0002
651 COLITIS ULCERATIVE 9 0.0002
652 ANAEMIA 38 0.0002
653 MIGRAINE 19 0.0002
654 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
655 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
656 INTENTIONAL SELF-INJURY 4 0.0002
657 HAEMATEMESIS 5 0.0002
658 ANXIETY 56 0.0002
659 INSURANCE ISSUE 3 0.0002
660 MALAISE 86 0.0002
661 EUPHORIC MOOD 2 0.0002
662 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
663 DIZZINESS 97 0.0002
664 TENDONITIS 3 0.0002
665 PERITONITIS 4 0.0002
666 ACUTE MYELOID LEUKAEMIA 3 0.0002
667 EYE DISCHARGE 2 0.0002
668 CARDIO-RESPIRATORY ARREST 8 0.0002
669 PRODUCT USE COMPLAINT 3 0.0002
670 BACK PAIN 44 0.0002
671 INCONTINENCE 2 0.0002
672 JOINT DISLOCATION 2 0.0002
673 DEPRESSED MOOD 10 0.0002
674 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
675 MOOD SWINGS 6 0.0002
676 METABOLIC ACIDOSIS 6 0.0002
677 HEREDITARY ANGIOEDEMA 2 0.0002
678 PHARYNGITIS STREPTOCOCCAL 2 0.0002
679 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
680 BLOOD CREATININE INCREASED 12 0.0002
681 PALLOR 5 0.0002
682 IRRITABILITY 11 0.0002
683 MYALGIA 31 0.0002
684 SKIN LESION 5 0.0002
685 VENTRICULAR TACHYCARDIA 3 0.0002
686 PHOTOSENSITIVITY REACTION 3 0.0002
687 STOMATITIS 11 0.0002
688 RESPIRATORY DISTRESS 5 0.0002
689 DENTAL CARIES 2 0.0002
690 FOOT DEFORMITY 2 0.0002
691 FEELING COLD 5 0.0002
692 BLOOD UREA INCREASED 3 0.0002
693 ORAL PAIN 4 0.0002
694 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
695 INTESTINAL PERFORATION 2 0.0002
696 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
697 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
698 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
699 PAIN IN JAW 5 0.0002
700 CIRCULATORY COLLAPSE 3 0.0002
701 DEPRESSION 40 0.0002
702 ELECTROLYTE IMBALANCE 2 0.0002
703 EYELID OEDEMA 2 0.0002
704 EOSINOPHILIA 3 0.0002
705 PALPITATIONS 20 0.0002
706 DIABETES MELLITUS 13 0.0002
707 SEPSIS 19 0.0002
708 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
709 CARDIAC ARREST 14 0.0002
710 LYMPHADENOPATHY 6 0.0002
711 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
712 HOSPITALISATION 26 0.0002
713 BLOOD IRON DECREASED 2 0.0002
714 NEUROPATHY PERIPHERAL 16 0.0002
715 COMA 8 0.0002
716 CEREBRAL HAEMORRHAGE 6 0.0002
717 WITHDRAWAL SYNDROME 7 0.0002
718 HEPATIC FAILURE 5 0.0002
719 TOOTHACHE 3 0.0002
720 APHASIA 5 0.0002
721 THERAPEUTIC RESPONSE DECREASED 10 0.0002
722 NEUTROPENIA 22 0.0002
723 AGRANULOCYTOSIS 3 0.0002
724 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
725 HYPERTENSION 34 0.0002
726 HYPOAESTHESIA 24 0.0002
727 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
728 BLOOD SODIUM DECREASED 3 0.0002
729 INCREASED APPETITE 3 0.0002
730 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
731 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
732 HEADACHE 97 0.0002
733 EAR PAIN 3 0.0002
734 INJECTION SITE INDURATION 2 0.0002
735 DIPLOPIA 4 0.0002
736 DEEP VEIN THROMBOSIS 10 0.0002
737 DYSPHONIA 9 0.0002
738 RESPIRATORY TRACT INFECTION 4 0.0002
739 SKIN FISSURES 3 0.0002
740 ECZEMA 8 0.0002
741 MEMORY IMPAIRMENT 21 0.0002
742 NEPHROLITHIASIS 7 0.0002
743 ARTHRITIS 12 0.0002
744 TINNITUS 7 0.0002
745 HAEMATOCRIT DECREASED 3 0.0002
746 OROPHARYNGEAL PAIN 14 0.0002
747 ADVERSE REACTION 2 0.0002
748 BLOOD PRESSURE INCREASED 23 0.0002
749 SKIN DISORDER 5 0.0001
750 PREGNANCY 3 0.0001
751 JOINT RANGE OF MOTION DECREASED 2 0.0001
752 PRODUCT ADMINISTRATION ERROR 3 0.0001
753 ARRHYTHMIA 7 0.0001
754 VERTIGO 9 0.0001
755 FEELING ABNORMAL 35 0.0001
756 RIB FRACTURE 3 0.0001
757 ATRIAL FIBRILLATION 14 0.0001
758 DERMATITIS 3 0.0001
759 WOUND 4 0.0001
760 CARPAL TUNNEL SYNDROME 2 0.0001
761 VOMITING 67 0.0001
762 HEART RATE DECREASED 5 0.0001
763 HYPERSOMNIA 4 0.0001
764 OEDEMA PERIPHERAL 17 0.0001
765 CARDIOGENIC SHOCK 2 0.0001
766 RHINORRHOEA 9 0.0001
767 AMNESIA 9 0.0001
768 PRODUCT DISPENSING ERROR 3 0.0001
769 DYSSTASIA 4 0.0001
770 MUSCULOSKELETAL STIFFNESS 12 0.0001
771 URINARY INCONTINENCE 4 0.0001
772 TOOTH DISORDER 3 0.0001
773 RASH MACULO-PAPULAR 3 0.0001
774 URINARY TRACT INFECTION 23 0.0001
775 HYPOTENSION 27 0.0001
776 PULMONARY OEDEMA 6 0.0001
777 HYPOAESTHESIA ORAL 2 0.0001
778 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
779 NAUSEA 104 0.0001
780 SYNCOPE 13 0.0001
781 LIMB DISCOMFORT 4 0.0001
782 ABDOMINAL PAIN 30 0.0001
783 COUGH 36 0.0001
784 ASTHENIA 48 0.0001
785 HAEMOGLOBIN DECREASED 13 0.0001
786 DISORIENTATION 5 0.0001
787 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
788 OBESITY 2 0.0001
789 SCIATICA 2 0.0001
790 ABSCESS 2 0.0001
791 MOBILITY DECREASED 9 0.0001
792 BLISTER 7 0.0001
793 SENSORY DISTURBANCE 2 0.0001
794 ABDOMINAL DISTENSION 13 0.0001
795 LOCALISED INFECTION 3 0.0001
796 LACTIC ACIDOSIS 4 0.0001
797 MUSCLE TIGHTNESS 2 0.0001
798 PRESYNCOPE 3 0.0001
799 BLOOD POTASSIUM INCREASED 2 0.0001
800 GASTROINTESTINAL DISORDER 11 0.0001
801 LIVER INJURY 3 0.0001
802 LETHARGY 7 0.0001
803 LUNG NEOPLASM MALIGNANT 5 0.0001
804 RASH 53 0.0001
805 EPISTAXIS 9 0.0001
806 LIP SWELLING 4 0.0001
807 FUNGAL INFECTION 4 0.0001
808 LEUKOPENIA 6 0.0001
809 CHILLS 14 0.0001
810 URTICARIA 20 0.0001
811 NASOPHARYNGITIS 22 0.0001
812 DIARRHOEA 77 0.0001
813 PERICARDITIS 2 0.0001
814 WEIGHT DECREASED 33 0.0001
815 HEMIPARESIS 2 0.0001
816 CHEST DISCOMFORT 12 0.0001
817 PRURITUS 45 0.0001
818 INFLUENZA 13 0.0001
819 ILLNESS 12 0.0001
820 MUSCULOSKELETAL DISCOMFORT 2 0.0001
821 SKIN ULCER 3 0.0001
822 BALANCE DISORDER 10 0.0001
823 MENTAL DISORDER 5 0.0001
824 PARAESTHESIA 18 0.0001
825 DERMATITIS ATOPIC 6 0.0001
826 COLD SWEAT 2 0.0001
827 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
828 GALLBLADDER DISORDER 2 0.0001
829 PRODUCT USE ISSUE 21 0.0001
830 WEIGHT INCREASED 25 0.0001
831 GOUT 2 0.0001
832 DISTURBANCE IN ATTENTION 6 0.0001
833 BLOOD BILIRUBIN INCREASED 3 0.0001
834 FREQUENT BOWEL MOVEMENTS 3 0.0001
835 GASTROENTERITIS VIRAL 2 0.0001
836 PNEUMONITIS 3 0.0001
837 ACCIDENTAL OVERDOSE 4 0.0001
838 HAEMATOCHEZIA 6 0.0001
839 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
840 DYSPNOEA 61 0.0001
841 FLATULENCE 6 0.0001
842 HYPOCALCAEMIA 2 0.0001
843 COLITIS 4 0.0001
844 CONFUSIONAL STATE 17 0.0001
845 DISEASE RECURRENCE 5 0.0001
846 MUSCULOSKELETAL DISORDER 2 0.0001
847 CHOLESTASIS 2 0.0001
848 POST PROCEDURAL COMPLICATION 2 0.0001
849 SEROTONIN SYNDROME 2 0.0001
850 PERIPHERAL SWELLING 16 0.0001
851 LIVER FUNCTION TEST ABNORMAL 3 0.0001
852 PLASMA CELL MYELOMA 4 0.0001
853 CHOKING 2 0.0001
854 KIDNEY INFECTION 2 0.0001
855 TACHYCARDIA 9 0.0001
856 DISABILITY 2 0.0001
857 THROMBOSIS 8 0.0001
858 ARTHRALGIA 41 0.0001
859 THROMBOCYTOPENIA 11 0.0001
860 BLINDNESS 4 0.0001
861 BODY TEMPERATURE INCREASED 2 0.0001
862 THERAPY INTERRUPTED 7 0.0001
863 THERAPY CESSATION 5 0.0001
864 PRODUCT PREPARATION ERROR 2 0.0001
865 INFLAMMATION 5 0.0001
866 SWOLLEN TONGUE 3 0.0001
867 PULMONARY HYPERTENSION 2 0.0001
868 SPEECH DISORDER 5 0.0001
869 KNEE ARTHROPLASTY 2 0.0001
870 PULMONARY EMBOLISM 9 0.0001
871 EATING DISORDER 2 0.0001
872 RETCHING 2 0.0001
873 FATIGUE 73 0.0001
874 CONTUSION 9 0.0001
875 HIP FRACTURE 3 0.0001
876 HYPERHIDROSIS 12 0.0001
877 SWELLING FACE 6 0.0001
878 PAIN IN EXTREMITY 27 0.0001
879 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
880 MELAENA 2 0.0001
881 ANGIOEDEMA 4 0.0001
882 GAIT INABILITY 3 0.0001
883 NECK PAIN 5 0.0001
884 PRODUCT DOSE OMISSION ISSUE 26 0.0001
885 PRODUCT AVAILABILITY ISSUE 2 0.0001
886 CHEST PAIN 16 0.0001
887 WHEEZING 5 0.0001
888 OCULAR HYPERAEMIA 4 0.0001
889 CATARACT 5 0.0001
890 RASH ERYTHEMATOUS 4 0.0001
891 BLOOD PRESSURE FLUCTUATION 2 0.0001
892 HEPATIC CANCER 2 0.0001
893 INFECTION 12 0.0001
894 CRYING 3 0.0001
895 FIBROMYALGIA 2 0.0001
896 INJECTION SITE URTICARIA 2 0.0001
897 DYSPEPSIA 8 0.0001
898 INJECTION SITE MASS 3 0.0001
899 EXPOSURE DURING PREGNANCY 5 0.0001
900 DRY EYE 4 0.0001
901 VISION BLURRED 11 0.0001
902 INTENTIONAL PRODUCT MISUSE 7 0.0001
903 HOT FLUSH 6 0.0001
904 FLUID RETENTION 4 0.0001
905 ERYTHEMA 16 0.0001
906 HAEMATOMA 2 0.0001
907 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
908 DEAFNESS 2 0.0001
909 JOINT STIFFNESS 2 0.0001
910 DISEASE PROGRESSION 9 0.0001
911 JOINT SWELLING 9 0.0001
912 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
913 FEAR 2 0.0001
914 EMOTIONAL DISTRESS 9 0.0001
915 PAIN OF SKIN 2 0.0001
916 EXTRA DOSE ADMINISTERED 3 0.0001
917 DRY MOUTH 6 0.0001
918 HEPATIC ENZYME INCREASED 5 0.0001
919 ALOPECIA 14 0.0001
920 HEART RATE INCREASED 7 0.0001
921 RED BLOOD CELL COUNT DECREASED 2 0.0001
922 ANGINA PECTORIS 2 0.0001
923 BLOOD GLUCOSE INCREASED 13 0.0001
924 FLUSHING 7 0.0001
925 NEEDLE ISSUE 2 0.0001
926 PAIN 42 0.0001
927 BONE PAIN 4 0.0001
928 SURGERY 4 0.0001
929 RENAL FAILURE 9 0.0001
930 BRONCHITIS 5 0.0001
931 OESOPHAGEAL CARCINOMA 2 0.0001
932 RESPIRATORY DISORDER 2 0.0001
933 PREMATURE BABY 2 0.0001
934 ABDOMINAL DISCOMFORT 11 0.0001
935 SKIN DISCOLOURATION 3 0.0001
936 FEELING HOT 4 0.0001
937 EMOTIONAL DISORDER 2 0.0001
938 VISUAL IMPAIRMENT 8 0.0001
939 BLOOD CHOLESTEROL INCREASED 3 0.0001
940 SWELLING 6 0.0001
941 NERVOUS SYSTEM DISORDER 2 0.0001
942 MYOCARDIAL INFARCTION 11 0.0001
943 INJECTION SITE BRUISING 5 0.0001
944 CARDIAC FAILURE CONGESTIVE 5 0.0001
945 ASTHMA 7 0.0001
946 LUNG DISORDER 3 0.0001
947 EYE PRURITUS 2 0.0001
948 HYPERSENSITIVITY 11 0.0001
949 INJECTION SITE PAIN 18 0.0001
950 SINUSITIS 6 0.0001
951 HAEMATURIA 2 0.0001
952 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
953 INJECTION SITE REACTION 4 0.0001
954 NEOPLASM PROGRESSION 2 0.0001
955 RASH MACULAR 2 0.0001
956 PANCREATITIS 3 0.0001
957 ABDOMINAL PAIN UPPER 11 0.0001
958 DEATH 46 0.0001
959 CEREBROVASCULAR ACCIDENT 9 0.0001
960 CHRONIC KIDNEY DISEASE 4 0.0001
961 PSORIATIC ARTHROPATHY 2 0.0000
962 SKIN EXFOLIATION 4 0.0000
963 DEVICE DISLOCATION 2 0.0000
964 DRUG WITHDRAWAL SYNDROME 4 0.0000
965 MUSCLE SPASMS 8 0.0000
966 INJURY 3 0.0000
967 BLOOD GLUCOSE DECREASED 2 0.0000
968 DRUG INTOLERANCE 4 0.0000
969 UNEVALUABLE EVENT 3 0.0000
970 NO ADVERSE EVENT 7 0.0000
971 MUSCULOSKELETAL PAIN 2 0.0000
972 DRUG DEPENDENCE 6 0.0000
973 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
974 RASH PRURITIC 2 0.0000
975 TREATMENT FAILURE 3 0.0000
976 ARTHROPATHY 2 0.0000
977 EYE PAIN 2 0.0000
978 INCORRECT DOSE ADMINISTERED 8 0.0000
979 BREAST CANCER 3 0.0000
980 PRODUCT QUALITY ISSUE 4 0.0000
981 HAEMORRHAGE 3 0.0000
982 DYSGEUSIA 2 0.0000
983 RHEUMATOID ARTHRITIS 3 0.0000
984 ACNE 2 0.0000
985 INJECTION SITE SWELLING 2 0.0000
986 INFLUENZA LIKE ILLNESS 2 0.0000
987 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
988 ADVERSE EVENT 2 0.0000
989 DRY SKIN 2 0.0000